Abstract 1832P
Background
According to Eurocare 6, the number of cancer survivors is increasing in Europe by 3,5% per year since 2010. Overall, 38% of all prevalent cases will live more than 10 years after the diagnosis. Colorectal cancer (CRC) stands as the 2nd most prevalent cancer among survivors across genders. Interestingly most CRC survivors will be older than 65 and will possibly need survivorship care services.
Methods
We investigated the cross-sectional association between physical-fitness, measured by the 6-minute walk test (6MWT), and isometric handgrip strength (IHS), and HRQoL (QLQ-C30 and QLQ-CR29) in a cohort of 272 Portuguese and Spanish CRC patients (mean age 65±10.8 years; 65% men; 10.5%, 21%, 33.6% and 28.7% in stages I, II, III and IV, respectively).
Results
Linear model analyses showed that greater performance in the 6MWT was associated with higher levels in several functional domains of QLQ-C30,such as physical scale (p=0.019), role (p<0.001), emotional (p=0.012), and cognitive function (p=0.012), and lower levels in several symptoms domains as fatigue (p=0.012), dyspnoea (p<0.001), insomnia (p=0.002) and appetite loss (p=0.001). Additionally, performance in 6MWT was associated with several functional domains of QLQ-CR29, as enhanced body image, less anxiety, and fewer weight problems (p=0.002, <0.001 and <0.001 respectively). Moreover, greater performance in IHS was associated with higher levels in role function (p<0.001) of QLQ-C30 and lower levels in several symptoms’ domains such as fatigue, pain, dyspnoea and insomnia (p<0.001, p=0.005, p=0.002 and p=0.014 respectively). Furthermore, performance in IHS was associated with several functional domains of QLQ-CR29, as improved body image, less anxiety, and fewer weight problems (p<0.001).
Conclusions
Our results suggest that greater aerobic fitness and upper-body muscle strength are associated with better functioning and lower symptomatology such as fatigue and pain. Additionally, greater aerobic fitness was associated with a better cognitive function. These findings support the need for rehabilitation strategies to enhance physical condition and quality of life in cancer survivors.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
CIAFEL: (UIDB/00617/2020: https://doi.org/10.54499/UIDB/00617/2020 and UIDP/00617/2020: https://doi.org/10.54499/UIDP/00617/2020) ITR: LA/P/0064/2020.
Disclosure
A. Ruiz-Casado: Financial Interests, Personal, Invited Speaker: Abbott, MEDTRONIC, Nestle, Servier; Financial Interests, Personal, Advisory Board: Amgen, Pierre Fabre. All other authors have declared no conflicts of interest.
Resources from the same session
1950P - Squamous cell carcinoma of unknown primary (SCCUP): A genomic landscape study
Presenter: Hannah Robinson
Session: Poster session 12
1951P - A multicenter, retrospective study of non-small-cell lung carcinoma (NSCLC) harboring EGFR exon 20 insertions: Distribution, variants, and prevalence of coalterations
Presenter: Ivana Gabriela Sullivan
Session: Poster session 12
1952P - Multiomic spatial profiling of whole-slide NSCLC tissues from patients receiving anti PD-1 therapy identifies metabolic phenotypes associated with therapy resistance
Presenter: Arutha Kulasinghe
Session: Poster session 12
1953P - The ATXN3-USP25-TRMT1 axis regulates tRNAm2,2G modification and promotes osimertinib resistance in lung cancer
Presenter: Tianqing Chu
Session: Poster session 12
Resources:
Abstract